—
C+
C+ The full Closelook — membership. Open the C+ overview

RadNet Inc (RDNT) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — RadNet Inc

RDNT in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
RadNet operates outpatient diagnostic imaging centres across the United States, offering MRI, CT, PET, mammography, ultrasound and other radiology procedures. It also builds AI software that reads breast, lung and prostate scans, and sells imaging archiving and workflow systems to other providers, alongside cloud tools that run radiology practices. The company is headquartered in Los Angeles.
Where it sits in the stack
RadNet holds no seat in our index. It belongs to the Diagnostics & Research sleeve of our universe, the group covering imaging, genomic testing and clinical-research services in the United States.
Who it is priced against
Its Closelook peer group is drawn from the same corner of diagnostics and research, ranked on trend rather than score: Medpace, Natera, GeneDx, Illumina, Guardant Health, ICON, IDEXX and Veracyte. The market also names Quest Diagnostics as a comparison in diagnostic services.
Why Closelook tracks it
RadNet carries no Closelook score and holds no seat in our index; the diary has not yet quoted it in an edition. Its peer cohort is ranked instead on trend state — distance from the 50- and 200-day averages — because no score exists to rank it on.
What the diary watches
The diary watches whether the shares hold their distance above the 200-day average, the trend measure its peer group is ranked on in the absence of a score.

RadNet Inc (RDNT) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-20. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for RDNT, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Diagnostics & Research · US · 8 names with week and year-to-date

Peer group

Diagnostics & Research · US

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against RDNT on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is RadNet Inc (RDNT)?

RadNet Inc trades as RDNT on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-19.

Is RDNT in a Closelook index?

Not currently — RadNet Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does RDNT trade against its moving averages?

Bullish stack, 200-day still turning: Trades +7.6% vs the 50-day and +15.5% vs the 200-day average, 11.5% below the 52-week high and +49.5% off the 52-week low; a golden cross printed 17 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does RadNet Inc do?

RadNet operates outpatient diagnostic imaging centres across the United States, offering MRI, CT, PET, mammography, ultrasound and other radiology procedures. It also builds AI software that reads breast, lung and prostate scans, and sells imaging archiving and workflow systems to other providers, alongside cloud tools that run radiology practices. The company is headquartered in Los Angeles. Its Closelook peer group is drawn from the same corner of diagnostics and research, ranked on trend rather than score: Medpace, Natera, GeneDx, Illumina, Guardant Health, ICON, IDEXX and Veracyte. The market also names Quest Diagnostics as a comparison in diagnostic services.

Where does RadNet Inc sit in the AI build-out?

RadNet holds no seat in our index. It belongs to the Diagnostics & Research sleeve of our universe, the group covering imaging, genomic testing and clinical-research services in the United States. RadNet carries no Closelook score and holds no seat in our index; the diary has not yet quoted it in an edition. Its peer cohort is ranked instead on trend state — distance from the 50- and 200-day averages — because no score exists to rank it on.

What does this page show?

A live price chart with SMA overlays and drawing tools for RDNT, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.